We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Pill patents

13 March 2012 By Jeff Glekin

India has joined Thailand and Brazil in granting a licence to a generic drugmaker at the expense of a global player. The likes of Bayer will protest but a compromise – with multinationals obliged to take a price hit in return for continued patent protection – is probable.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)